Assets változás Dátum
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Cytokinetics USD 824.32M 83.7M 2023-12
Daiichi Sankyo JPY 2.65T 33.03B 2023-09
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
TG Therapeutics USD 329.59M 1.48M 2023-12
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Xencor USD 952.69M 174.26M 2023-12



PTC Therapeutics Eszközök - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.